DJ AstraZeneca PLC ADR Falls Thursday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
The AstraZeneca PLC ADR $(AZN)$ slid 0.80% to $75.80 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 1.51% to 15,840.96 and the Dow Jones Industrial Average rising 0.85% to 38,225.66.
The ADR's fall snapped a nine-day winning streak.
AstraZeneca PLC ADR closed $1.00 below its 52-week high ($76.80), which the company reached on May 1st.
Despite its losses, the ADR outperformed some of its competitors Thursday, as Eli Lilly & Co. $(LLY)$ fell 2.68% to $755.91, Biogen Inc. $(BIIB)$ fell 1.21% to $213.51, and Johnson & Johnson $(JNJ)$ fell 0.83% to $149.92.
Trading volume (9.2 M) eclipsed its 50-day average volume of 5.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 2, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 02, 2024 17:26 ET (21:26 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments